Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | GENOMICS ENGLAND LIMITED |
| Main Category: | Services |
| Procurement Method: | Direct award |
| Method Rationale: | Additional or repeat goods, services or works - further goods, services or works following a competitive procedure The Contracting Authority proposes to award the contract for the continuation of evaluation services for the Generation Study directly to UCL Consultants Limited (UCL) pursuant to the provisions of Schedule 5, Part 7 of the Procurement Act 2023. Under this statutory framework, a direct award is permissible where the public contract concerns the supply of services by the existing supplier, intended as an extension to, or partial replacement of, existing services, and where specific conditions are satisfied. In the present circumstances, the evaluation services to be provided by UCL are a direct extension of the supplier's existing contractual obligations and are integral to the ongoing delivery of the Generation Study. The Authority has determined that a change in supplier would result in the receipt of services that are materially different from, or incompatible with, those previously supplied, as contemplated by paragraph 7(a) of Schedule 5. UCL has established bespoke methodologies, data structures, and analytical frameworks which are essential to the continuity and integrity of the evaluation process. The introduction of an alternative supplier would give rise to disproportionate technical difficulties in operation and maintenance, including, but not limited to, the risk of inconsistency in longitudinal data collection, misalignment of analytical processes, and disruption to established reporting mechanisms, as set out in paragraph 7(b). Accordingly, the authority is satisfied that the proposed direct award to UCL is both necessary and proportionate, ensuring the seamless continuation of services and safeguarding the technical integrity of the Generation Study. This approach is fully compliant with the statutory requirements and transparency obligations set out in the Procurement Act 2023. |
All 4 notices for this procurement, oldest first.
Process and Impact Evaluation Phase 3
Process and Impact Evaluation Phase 3
Process and Impact Evaluation Phase 3
Process and Impact Evaluation Phase 3 - Generation Study
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award status: | Active |
To provide comprehensive process and impact evaluation services for the Newborns Genome Programme ("Generation Study"). The required services include conducting interviews with designers and early implementers of the Generation Study, administering surveys and follow-up interviews with parents twelve months after completion of the initial survey, and undertaking micro-costing analyses to assess changes in resource use and costs as the programme scales. All data collection and analysis shall be performed using approved qualitative and quantitative methods, under the oversight of the Study Advisory Group and the Patient and Public Involvement and Engagement (PPIE) Advisory Group.
Published contracts in the last 12 months
151
total contracts
£1.4m
total value
£104,882
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 2 February 2026 |
| Application Deadline: | — |
| Procurement ID (OCID): | ocds-h6vhtk-05e9b3 |
| Notice Reference: | 008986-2026 |